Hair Loss and Effectiveness
Yes, 66.3% of patients in the multi-center clinical study kept at least 50% of their hair. Typically, patients will start to see shedding (usually this is o...
Tue, 25 May, 2021 at 11:14 AM
Clinical success The DigniCap Clinical trial demonstrated a success rate of about 66% for patients on Taxane-based regimens. (Success is defined as losing...
Mon, 19 Apr, 2021 at 12:18 PM
Scalp cooling works by constricting the blood vessels, limiting the amount of chemo being introduced to the hair follicle, thus reducing the amount of hair ...
Wed, 6 Sep, 2023 at 8:41 PM
No. DigniCap prevents hair loss on the scalp area, where cooling is applied and therefore does not prevent eyebrow or eyelashes from thinning.
Tue, 17 Oct, 2017 at 11:47 AM
Cooling of the scalp is a proven approach to reduce chemotherapy-induced hair loss that has been used successfully by thousands of patients worldwide with a...
Fri, 16 Jun, 2023 at 1:50 PM
Scalp cooling has been evaluated mainly with regimens including anthracyclines (such as doxorubicin and epirubicin) and taxanes (such as paclitaxel and docet...
Tue, 17 Oct, 2017 at 1:18 PM
No. Scalp metastases is the development of secondary malignancy at a site away from the primary cancer growth. Scalp cooling does not increase this risk, ...
Tue, 17 Oct, 2017 at 1:26 PM
If you are still in treatment or your hair is still recovering and fragile, DigniCap does not recommend using any product or device that adds heat, which in...
Mon, 4 Dec, 2023 at 12:41 PM